Trademark: 88832781
Word
FOXO BIOSCIENCE
Status
Pending
Status Code
688
Status Date
Tuesday, September 19, 2023
Serial Number
88832781
Mark Type
4000
Filing Date
Thursday, March 12, 2020
Published for Opposition
Tuesday, May 2, 2023

Trademark Owner History
FOXO TECHNOLOGIES INC. - Owner At Publication
Foxo Bioscience, LLC - Original Applicant

Classifications
41 Providing an online resource center, namely, online non-downloadable articles and papers in the fields of longevity, aging, genetic and epigenetic testing and genotyping and genomic technologies; Providing a website featuring online non-downloadable publications in the nature of articles, journals, brochures, leaflets, guides and manuals in the fields of longevity, aging, genetic and epigenetic testing and genotyping and genomic technologies; Providing an online publication in the nature of an non-downloadable interactive encyclopedia in the fields of longevity, aging, genetic and epigenetic testing and genotyping and genomic technologies; Educational services, namely, providing seminars, workshops, customer trainings and tutorials in the fields of, and for use in the fields of, health and aging tips and strategies, disease prevention, nucleic acid sequencing, genetics, epigenetics, genotyping, genomics, metagenomics, medical diagnostics, veterinary diagnostics, clinical diagnostics, medical research, veterinary research, clinical research, drug development, drug development research, medical laboratory research, veterinary science and research, life sciences, biology, microbiology, biotechnology, agriculture, forensics, food safety, population research, and actuarial services; Providing non-downloadable electronic newsletters and online non-downloadable electronic newsletters delivered via email for use in the fields of health and aging tips and strategies, disease prevention, nucleic acid sequencing, genetics, epigenetics, genotyping, genomics, metagenomics, medical diagnostics, veterinary diagnostics, clinical diagnostics, medical research, veterinary research, clinical research, drug development, drug development research, medical laboratory research, veterinary science and research, life sciences, biology, microbiology, biotechnology, agriculture, forensics, food safety, population research, and actuarial services; Educational services, namely, providing training of clinicians, scientists, researchers and medical professionals in the use of scientific equipment, instruments and techniques, namely, genomic sequencers, molecular diagnostic technologies, microarray technologies, DNA extraction, bioinformatics, and automated laboratory apparatus; Providing facilities for training in operation and use of scientific equipment, instruments and techniques, namely, genomic sequencers, molecular diagnostic technologies, microarray technologies, DNA extraction, bioinformatics, and automated laboratory apparatus
9 Computer systems, namely, computer hardware, downloadable computer software, and downloadable electronic data files for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes, and excluding software that facilitates communication, collaboration, networking and the sharing of medical information and imaging between medical professionals with other medical professionals and medical service providers; Downloadable computer software for data collection, management, and analysis of molecular health, genetic and epigenetic information for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes, excluding software that facilitates communication, collaboration, networking and the sharing of medical information and imaging between medical professionals with other medical professionals and medical service providers
5 Medical diagnostic reagents; Clinical medical diagnostic reagents
36 Insurance information and consultancy; Insurance services, namely, insurance eligibility review and verification and consultation in the life insurance industry; Insurance services, namely, underwriting, issuing and administration of life insurance; Insurance agency and brokerage
1 Epigenetic test kits comprising reagents for testing and analyzing saliva for non-medical purposes; Reagent kits and beads with attached biomolecules, comprised primarily of oligonucleotides and other nucleic acids, natural and modified nucleotides, polypeptides, buffers, labels, and substrates, for clinical diagnostic purposes
45 Online social networking services in the field of genetics and epigenetics
44 Medical testing for screening, diagnostic or prognostic purposes; DNA sequencing, screening, and analysis services for medical diagnostic purposes; Nucleic acid sequencing, screening, and analysis services for medical diagnostic purposes; Genomic sequencing, screening, and analysis services for medical diagnostic purposes; Genetic and epigenetic analysis and reporting services for medical diagnostic purposes; Medical diagnostic testing, monitoring and reporting services in the field of infectious disease identification and surveillance
42 Providing scientific analysis in the field of personal epigenetics; Reporting of consumer authorized molecular health, aging and longevity results direct to the consumer for non-medical purposes, namely, epigenetic testing, analysis and evaluation of saliva; Testing, analysis and evaluation of DNA for epigenetic patterns associated with alcohol and tobacco use and other traits about an individual for non-medical purposes; Providing an interactive website featuring technology that allows users to enter, access, track, monitor and generate information and reports in the fields of personal epigenetics, health and wellness
"BIOSCIENCE"

Trademark Events
Sep 19, 2023
Noa E-Mailed - Sou Required From Applicant
Aug 10, 2023
Extension Of Time To Oppose Process - Terminated
Jun 1, 2023
Extension Of Time To Oppose Received
May 2, 2023
Official Gazette Publication Confirmation E-Mailed
May 2, 2023
Published For Opposition
Apr 12, 2023
Notification Of Notice Of Publication E-Mailed
Mar 30, 2023
Law Office Publication Review Completed
Mar 23, 2023
Assigned To Lie
Mar 9, 2023
Approved For Pub - Principal Register
Mar 8, 2023
Teas/Email Correspondence Entered
Mar 8, 2023
Correspondence Received In Law Office
Mar 8, 2023
Teas Request For Reconsideration Received
Dec 16, 2022
Notification Of Final Refusal Emailed
Dec 16, 2022
Final Refusal E-Mailed
Dec 16, 2022
Final Refusal Written
Nov 18, 2022
Preliminary/Voluntary Amendment - Entered
Nov 18, 2022
Teas Voluntary Amendment Received
Oct 28, 2022
Teas/Email Correspondence Entered
Oct 27, 2022
Correspondence Received In Law Office
Oct 27, 2022
Teas Response To Office Action Received
Apr 27, 2022
Notification Of Non-Final Action E-Mailed
Apr 27, 2022
Non-Final Action E-Mailed
Apr 27, 2022
Non-Final Action Written
Apr 20, 2022
Previous Allowance Count Withdrawn
Apr 20, 2022
Approved For Pub - Principal Register
Mar 31, 2022
Teas/Email Correspondence Entered
Mar 30, 2022
Correspondence Received In Law Office
Mar 30, 2022
Teas Response To Office Action Received
Nov 17, 2021
Teas Change Of Correspondence Received
Nov 17, 2021
Teas Withdrawal Of Attorney Received-Firm Retains
Nov 17, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 17, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 30, 2021
Notification Of Non-Final Action E-Mailed
Sep 30, 2021
Non-Final Action E-Mailed
Sep 30, 2021
Non-Final Action Written
Aug 30, 2021
Suspension Checked - To Attorney For Action
Aug 12, 2021
Assigned To Examiner
Aug 2, 2021
Suspension Checked - To Attorney For Action
Jul 9, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Jul 9, 2021
Teas Change Of Correspondence Received
Jul 9, 2021
Teas Withdrawal Of Attorney Received-Firm Retains
Jul 9, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 9, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 9, 2021
Teas Change Of Owner Address Received
May 19, 2021
Automatic Update Of Assignment Of Ownership
Oct 20, 2020
Notification Of Letter Of Suspension E-Mailed
Oct 20, 2020
Letter Of Suspension E-Mailed
Oct 20, 2020
Suspension Letter Written
Sep 29, 2020
Teas/Email Correspondence Entered
Sep 28, 2020
Correspondence Received In Law Office
Sep 28, 2020
Teas Response To Office Action Received
Mar 26, 2020
Notification Of Non-Final Action E-Mailed
Mar 26, 2020
Non-Final Action E-Mailed
Mar 26, 2020
Non-Final Action Written
Mar 21, 2020
Assigned To Examiner
Mar 19, 2020
New Application Office Supplied Data Entered
Mar 16, 2020
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24